- Introductory chapters provide good general overview of HLA field for novice immunologists and geneticists
- Up-to-date, complete listing of HLA alleles
- Invaluable reference resource for immunologists, geneticists, and cell biologists
- Combines both structural and functional information, which has never been compiled in a single reference book previously
- Serological specificity of allotypes
- Identity of material sequenced including ethnic origin
- Database accession numbers
- Population distribution
- Peptide binding specificities
- T cell epitopes
- Amino acid sequences of allotypes
- Key references
The Introductory Chapters:
Human Leukocyte Antigens (HLA) Determine Histocompatibility in Transplantation.
The Organisation of HLA Genes Within the HLA Complex.
HLA Class I Antigens and Alleles: Workshops and Nomenclature.
HLA Class II Antigens and Alleles: Workshops and Nomenclature.
HLA Typing at the DNA Level.
HLA Class I and II Molecules Present Peptide Antigens to Different Types of T Cell.
HLA Class I Molecules Control Natural Killer Cell Function.
Three-Dimensional Structures of HLA Class I Molecules.
Three-Dimensional Structures of HLA Class II Molecules.
HLA Polymorphism, Peptide Binding Motifs and T-Cell Epitopes.
Evolution and Anthropology of HLA.
HLA and Disease.
Alloreactions in Transplantation.
The HLA Class I and Class II Loci.
Dr. Parham was born in London and read natural sciences at Cambridge University. He began study of the genetic basis of HLA polymorphism in 1973 and has continued this line of research ever since. Dr. Parham is currently Professor of structural biology and microbiology and immunology at Stanfor University.
Barber, Linda D.
Linda Barber's doctoral and post-doctoral studies examined the structure and function of MHC classI and classII molecules with emphasis on the impact of polymorphism on peptides bound and presented for immune surveillance. Dr. Barber's current interests focus on utilizing our understanding of the role of MHC molecules in T cell and NK cell function to develop improved prophylatic and therapeutic strategies for manipulating immune responses.